| ALCON AG NAM. SF -,04 |
| Schweiz |
| Gesundheit |
| CH0432492467 / A2PDXE |
| 2U3 (Frankfurt) / ALC (NYSE) |
| FRA:2U3, ETR:2U3, 2U3:GR, NYSE:ALC |
| SMI |
| https://www.alcon.com/ |
|
Alcon Inc. is a leading global vision care company specializing in the development, manufacture, and marketing of surgical equipment, devices, pharmaceutical eye drops, and consumer vision care produc..
>Volltext.. |
| 34927.98 Mio. EUR |
| 38118.28 Mio. EUR |
| 9231.25 Mio. EUR |
| 2516.2 Mio. EUR |
| 958.67 Mio. EUR |
| 1.94 EUR |
| 4445.89 Mio. EUR |
| 1270.98 Mio. EUR |
| 1824.76 Mio. EUR |
| 0.5 |
| 1.36% |
| -11.49% |
| - |
| 0.44% |
| 0.44% |
| 10.05.23 - 0.22703099€ 03.05.22 - 0.21622€ >weitere anzeigen... |
| - |
| ALCON |
| 25.02.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|